Why Reinvention Matters for the Chemical Industry
Chemical companies face rising volatility, weak demand and structural challenges. AI-powered reinvention can offer a path to faster growth, lower costs and greater competitiveness by transforming how work gets done.
Bernd Elser, Senior Managing Director, Global Chemicals & Natural Resources Lead, Accenture

Chemical companies face rising volatility, weak demand, and structural challenges. AI-powered reinvention can offer a path to faster growth, lower costs, and greater competitiveness by transforming how work gets done.
Anyone currently working in the chemical industry is acutely aware of the challenges we face—geopolitical conflict, logistics disruptions, regulatory intervention, and more. The question becomes, how does the industry return to what it does best, innovating, producing and selling, during times of unprecedented change and almost daily disruption. It’s a question that Accenture attempted to answer in our most recent report.
Compounding these external pressures are industry specific challenges including slowdowns in key end markets, overbuilt value chains that are creating supply and demand imbalances, stagnant views on how work should be organized and the looming retirement wave. These circumstances are creating an environment that is making it extremely difficult for chemical companies to return to growth and provide shareholder value.
A Traditional Response to an Untraditional Problem
Continue with login
No account yet?
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
Registermost read

20 Years of CHEManager International
Incredible but true: CHEManager International is celebrating its 20th anniversary!

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0

Lead or Lag: Europe’s AI Materials Race
How AI and Robotics are reshaping the race for materials discovery.

US Tariffs Fatal for European Pharma
Trump's tariff policy is a considerable burden and a break with previous practice.

ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.









